Whats your view on Piramal Pharma for coming 3-6 months?

Ans: Decline in Quarterly Net Profit with falling Profit Margin (YoY) and weak financials. This needs to be changed, check this quarterly results and then take action accordingly.

Disclaimer: Investments in securities are subject to market RISKS. Read all the related documents carefully before investing. Please consult your appointed/paid financial adviser before taking any decision. The securities quoted are for illustration only and are not recommendatory. Registration granted by SEBI, membership of BASL and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.